Page 76 - AN-2-1

Advanced Neurology Alpha-synuclein, depression and neurodegeneration

24. Fan DY, Wang YJ, 2020, Early intervention in Alzheimer’s review and meta-analysis of longitudinal studies. Int J
disease: How early is early enough? Neurosci Bull, Geriatr Psychiatry, 37: 5711.
36: 195–197.
https://doi.org/10.1002/gps.5711
https://doi.org/10.1007/s12264-019-00429-x
35. Saiz-Vazquez O, Gracia-Garcia P, Ubillos-Landa P, et al.,
25. Mahlknecht P, Marini K, Werkmann M, et al., 2022, 2021, Depression as a risk factor for Alzheimer’s disease:
Prodromal Parkinson’s disease: Hype or hope for disease- A systematic review of longitudinal meta-analyses. J Clin
modification trials? Transl Neurodegener, 11: 11. Med, 10: 1809.
https://doi.org/10.1186/s40035-022-00286-1 https://doi.org/10.3390/jcm10091809
26. Alvarez-Sanchez L, Pena-Bautista C, Baquero M, et al., 36. Tran AA, De Smet M, Grant GD, et al., 2020, Investigating
2022, Novel ultrasensitive detection technologies for the the convergent mechanisms between major depressive
identification of early and minimally invasive Alzheimer’s disorder and Parkinson’s disease. Complex Psychiatry,
disease blood biomarkers. J Alzheimers Dis, 86: 1337–1369. 6: 47–61.
https://doi.org/10.3233/jad-215093 https://doi.org/10.1159/000512657
27. Chelliah SS, Bhuvanendran S, Magalingam KB, et al., 2022, 37. Novellino F, Sacca V, Donato A, et al., 2020, Innate immunity:
Identification of blood-based biomarkers for diagnosis and A common denominator between neurodegenerative and
prognosis of Parkinson’s disease: A systematic review of neuropsychiatric diseases. Int J Mol Sci, 21: 1115.
proteomics studies. Ageing Res Rev, 73: 101514.
https://doi.org/10.3390/ijms21031115
https://doi.org/10.1016/j.arr.2021.101514
38. Hussain M, Kumar P, Khan S, et al., 2020, Similarities
28. Aisen PS, Jimenez-Maggiora GA, Rafii MS, et al., 2022, between depression and neurodegenerative diseases:
Early-stage Alzheimer disease: Getting trial-ready. Nat Rev Pathophysiology, challenges in diagnosis and treatment
Neurol, 18: 389–399. options. Cureus, 12: e11613.
https://doi.org/10.1038/s41582-022-00645-6 https://doi.org/10.7759/cureus.11613
29. Kuring JK, Mathias JL, Ward L, 2020, Risk of dementia 39. Luo J, Beam CR, Gatz M, 2022, Is stress an overlooked risk
in persons who have previously experienced clinically- factor for dementia? A systematic review from a lifespan
significant depression, anxiety, or PTSD: A systematic perspective. Prev Sci.
review and meta-analysis. J Affect Disord, 274: 247–261.
https://doi.org/10.1007/s11121-022-01385-1
https://doi.org/10.1016/j.jad.2020.05.020
40. Hahad O, Lelieveld J, Birklein F, et al., 2020, Ambient
30. Bareeqa SB, Samar SS, Kamal S, et al., 2022, Prodromal air pollution increases the risk of cerebrovascular
depression and subsequent risk of developing Parkinson’s and neuropsychiatric disorders through induction of
disease: A systematic review with meta-analysis. inflammation and oxidative stress. Int J Mol Sci, 21: 4306.
Neurodegener Dis Manag, 12: 155–164.
https://doi.org/10.3390/ijms21124306
https://doi.org/10.2217/nmt-2022-0001
41. Chiavegatto S, Izidio GS, Mendes-Lana A, et al., 2009,
31. Zhao Q, Xiang H, Cai Y, et al., 2022, Systematic evaluation of Expression of α-synuclein is increased in the hippocampus
the associations between mental disorders and dementia: An of rats with high levels of innate anxiety. Mol Psychiatry,
umbrella review of systematic reviews and meta-analyses. 14: 894–905.
J Affect Disord, 307: 301–309.
https://doi.org/10.1038/mp.2008.43
https://doi.org/10.1016/j.jad.2022.03.010
42. Miquel-Rio L, Alarcon-Aris D, Torres-Lopez M, et al., 2022,
32. Walter U, Heilmann R, Kaulitz L, et al., 2015, Prediction of Human α-synuclein overexpression in mouse serotonin
Parkinson’s disease subsequent to severe depression: A ten- neurons triggers a depressive-like phenotype. Rescue by
year follow-up study. J Neural Transm, 122: 789–797. oligonucleotide therapy. Transl Psychiatry, 12: 79.
https://doi.org/10.1007/s00702-014-1313-0 https://doi.org/10.1038/s41398-022-01842-z
33. Wang S, Mao S, Xiang D, et al., 2018, Association between 43. Zhao X, Kong D, Zhou Q, et al., 2021, Baicalein alleviates
depression and the subsequent risk of Parkinson’s disease: depression-like behavior in rotenone-induced Parkinson’s
A meta-analysis. Prog Neuropsychopharmacol Biol disease model in mice through activating the BDNF/TrkB/
Psychiatry, 86: 186–192. CREB pathway. Biomed Pharmacother, 140: 111556.
https://doi.org/10.1016/j.pnpbp.2018.05.025 https://doi.org/10.1016/j.biopha.2021.111556
34. Stafford J, Chung WT, Sommerlad A, et al., 2022, Psychiatric 44. Burtscher J, Copin JC, Rodrigues J, et al., 2019, Chronic
disorders and risk of subsequent dementia: Systematic corticosterone aggravates behavioral and neuronal

Volume 2 Issue 1 (2023) 11 https://doi.org/10.36922/an.326